Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study.
Journal
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
ISSN: 2148-5607
Titre abrégé: Turk J Gastroenterol
Pays: Turkey
ID NLM: 9515841
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
entrez:
26
7
2022
pubmed:
27
7
2022
medline:
28
7
2022
Statut:
ppublish
Résumé
Seroepidemiology, risk factors to hepatitis E virus exposure, and prevalence of hepatitis E virus viremia have not yet been investigated among patients under immunosuppression or with liver disease that are high risk for infection in Turkey. In this cross-sectional study, 292 consecutive serum samples from renal transplant recipients, allogeneic hematopoietic stem cell transplant recipients, patients with acute hepatitis, and patients with chronic hepatitis C were prospectively collected in a ter- tiary university hospital. Sera were tested for hepatitis E virus immunoglobulin G/immunoglobulin M and hepatitis E virus ribonucleic acid using commercial enzyme-linked immunosorbent assay and in-house nested polymerase chain reaction with Sanger sequencing, respectively. Sociodemographic, clinical, laboratory data, and risk factors were collected using a questionnaire and hospital database. Multiple logistic regression analysis was employed to identify independent predictors for anti-hepatitis E virus seropositivity. Among all patients, only 2 patients (1 renal transplant recipient and 1 patient with acute hepatitis) were identified as having hepatitis E virus genotype 3 viremia. Hepatitis E virus viremia rate was 0.6% in whole group. These patients showed no signs of chronic hepatitis E virus infection for 6 months and were spontaneously seroconverted 6 months after enrollment. Anti-hepatitis E virus IgG was positive in 29 patients yielding a hepatitis E virus seroprevalence of 9.9%. Older age (adjusted odds ratio: 1.03, 95% CI, 1.00-1.06; P = .022) and eating undercooked meat (adjusted odds ratio: 3.11, 95% CI, 1.08-8.92; P = .034) were independent risk factors to anti- hepatitis E virus seropositivity in all patients. Similarly, multiple logistic regression analysis demonstrated that age (adjusted odds ratio: 1.03, 95% CI, 0.99-1.07, P = .058) and eating undercooked meat (adjusted odds ratio: 5.77, 95% CI, 1.49-22.25, P = .011) were indepen- dent risk factors for anti-hepatitis E virus IgG positivity in the liver disease subgroup consisting of acute hepatitis and chronic hepatitis C patients. The hepatitis E virus seroprevalence rate was high (9.9%), despite low viremia rate (0.6%) in high-risk patients. The emer- gence of hepatitis E virus genotype 3 might indicate a serious problem for these patients. Future investigations are needed to elucidate foodborne transmission routes of hepatitis E virus in Turkey.
Sections du résumé
BACKGROUND
Seroepidemiology, risk factors to hepatitis E virus exposure, and prevalence of hepatitis E virus viremia have not yet been investigated among patients under immunosuppression or with liver disease that are high risk for infection in Turkey.
METHODS
In this cross-sectional study, 292 consecutive serum samples from renal transplant recipients, allogeneic hematopoietic stem cell transplant recipients, patients with acute hepatitis, and patients with chronic hepatitis C were prospectively collected in a ter- tiary university hospital. Sera were tested for hepatitis E virus immunoglobulin G/immunoglobulin M and hepatitis E virus ribonucleic acid using commercial enzyme-linked immunosorbent assay and in-house nested polymerase chain reaction with Sanger sequencing, respectively. Sociodemographic, clinical, laboratory data, and risk factors were collected using a questionnaire and hospital database. Multiple logistic regression analysis was employed to identify independent predictors for anti-hepatitis E virus seropositivity.
RESULTS
Among all patients, only 2 patients (1 renal transplant recipient and 1 patient with acute hepatitis) were identified as having hepatitis E virus genotype 3 viremia. Hepatitis E virus viremia rate was 0.6% in whole group. These patients showed no signs of chronic hepatitis E virus infection for 6 months and were spontaneously seroconverted 6 months after enrollment. Anti-hepatitis E virus IgG was positive in 29 patients yielding a hepatitis E virus seroprevalence of 9.9%. Older age (adjusted odds ratio: 1.03, 95% CI, 1.00-1.06; P = .022) and eating undercooked meat (adjusted odds ratio: 3.11, 95% CI, 1.08-8.92; P = .034) were independent risk factors to anti- hepatitis E virus seropositivity in all patients. Similarly, multiple logistic regression analysis demonstrated that age (adjusted odds ratio: 1.03, 95% CI, 0.99-1.07, P = .058) and eating undercooked meat (adjusted odds ratio: 5.77, 95% CI, 1.49-22.25, P = .011) were indepen- dent risk factors for anti-hepatitis E virus IgG positivity in the liver disease subgroup consisting of acute hepatitis and chronic hepatitis C patients.
CONCLUSION
The hepatitis E virus seroprevalence rate was high (9.9%), despite low viremia rate (0.6%) in high-risk patients. The emer- gence of hepatitis E virus genotype 3 might indicate a serious problem for these patients. Future investigations are needed to elucidate foodborne transmission routes of hepatitis E virus in Turkey.
Identifiants
pubmed: 35879919
doi: 10.5152/tjg.2022.21493
pmc: PMC9404861
doi:
Substances chimiques
Hepatitis Antibodies
0
Immunoglobulin G
0
RNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
615-624Références
Br J Haematol. 2019 Jul;186(1):191-195
pubmed: 30768677
Blood. 2013 Aug 8;122(6):1079-86
pubmed: 23794068
J Clin Virol. 2013 Dec;58(4):629-34
pubmed: 24210958
Ann Clin Microbiol Antimicrob. 2018 May 2;17(1):17
pubmed: 29716597
Virology. 1991 Nov;185(1):120-31
pubmed: 1926770
N Engl J Med. 2008 Feb 21;358(8):811-7
pubmed: 18287603
Viruses. 2021 Apr 13;13(4):
pubmed: 33924409
J Med Virol. 2019 Dec;91(12):2174-2181
pubmed: 31403185
Transplantation. 2018 Jul;102(7):1139-1147
pubmed: 29953421
J Clin Microbiol. 2002 Sep;40(9):3209-18
pubmed: 12202555
Transfusion. 2015 Jul;55(7):1662-7
pubmed: 25819381
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
J Viral Hepat. 2021 Nov;28(11):1643-1655
pubmed: 34415657
Science. 1990 Mar 16;247(4948):1335-9
pubmed: 2107574
Gastroenterology. 2011 May;140(5):1481-9
pubmed: 21354150
Euro Surveill. 2016 Jun 29;22(26):
pubmed: 28681720
Int J Infect Dis. 2020 Feb;91:188-195
pubmed: 31756566
BMC Infect Dis. 2016 Nov 8;16(1):659
pubmed: 27825308
Viruses. 2016 Aug 06;8(8):
pubmed: 27509518
Curr Opin Virol. 2014 Feb;4:91-6
pubmed: 24513966
N Engl J Med. 2012 Sep 27;367(13):1237-44
pubmed: 23013075
Lancet. 2014 Nov 15;384(9956):1766-73
pubmed: 25078306
Transfusion. 2017 Dec;57(12):2958-2964
pubmed: 28833188
Emerg Infect Dis. 2011 Dec;17(12):2309-12
pubmed: 22172156
World J Gastroenterol. 2020 Oct 7;26(37):5543-5560
pubmed: 33071523
Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
pubmed: 7984417
Liver Int. 2021 Mar;41(3):449-455
pubmed: 33034121
Gastroenterology. 2016 Feb;150(2):355-7.e3
pubmed: 26551551
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712